Immunovant, Inc. (IMVT) stock
IMVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
$33.21−0.07 (-0.21%)
Close on Nov 17, 2026Market cap $6.86BP/E –Yield –
Immunovant profit margin
Profit margin (net margin) is net income as a percentage of revenue.
No profit margin figures for Immunovant
Immunovant has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?